Galapagos Sees Global Market For Point-Of-Care CAR-T But Is Still On M&A Trail

CEO Hires Ex J&J Colleague To Continue Company Reinvention

Paul Stoffels is continuing his transformation of Galapagos into a company with CAR-T and small molecule platforms and is aiming to seal more M&A deals before the end of this year.

Stoffels_Paul
Paul Stoffels has made its acquired 'point of care' CAR-T tech a key bet for Galapagos, but hopes to seal more M&A deals this year.

More from Anticancer

More from Therapy Areas